Narrow search
Showing 1 - 10 of 402
Cover Image
The Birth of German Biotechnology Industry: Did Venture Capital run the Show?
Heneric, Oliver; Engel, Dirk; Champenois, Claire - 2004
The goal of this paper is to point out the role played by private equity investors (venture-capital companies and corporate investors) in the emergence of a new biotechnology industry in Germany in the second half of the 90?s. This analysis takes into account the different business models and...
Persistent link: https://www.econbiz.de/10010297325
Cover Image
What kind of German biotechnology start-ups do venture capital companies and corporate investors prefer for equity investments?
Champenois, Claire; Engel, Dirk; Heneric, Oliver - In: Applied economics 38 (2006) 5, pp. 505-518
Persistent link: https://www.econbiz.de/10003309097
Cover Image
Venture Capital bedeutend für die Entstehung der Biotechnologiebranche
Champenois, Claire; Engel, Dirk; Heneric, Oliver - In: ZEW-Gründungsreport 3 (2003) 1, pp. 1-2
15 Prozent der zwischen 1995 und 1999 neu gegründeten Biotechnologieunternehmen erhielten Venture Capital (VC). Am begehrtesten waren Medikamenten- und Wirkstoffentwickler sowie Dienstleister im Bereich medizinischer Anwendungen. Hier wurde nahezu jedes dritte Unternehmen mit VC finanziert.
Persistent link: https://www.econbiz.de/10010501533
Cover Image
The Birth of German Biotechnology Industry - Did Venture Capital run the show?
Heneric, Oliver; Engel, Dirk; Champenois, Claire - 2004
We answer the questions, how many firms acting in the modern German biotechnology industry are funded by venture capital companies (VCC) as well as equity funded by corporate investors. The theory suggests a high relevance of VCC as venturing partner of high-tech projects. In addition we argue...
Persistent link: https://www.econbiz.de/10010261021
Cover Image
The birth of German biotechnology industry : did venture capital run the show?
Champenois, Claire (contributor); Engel, Dirk (contributor);  … - 2004 - [Elektronische Ressource]
Persistent link: https://www.econbiz.de/10002096010
Cover Image
The birth of German biotechnology industry : did venture capital run the show?
Champenois, Claire (contributor); Engel, Dirk (contributor);  … - 2004 - [Elektronische Ressource]
Persistent link: https://www.econbiz.de/10001898408
Cover Image
The Birth of German Biotechnology Industry : Did Venture Capital Run the Show?
Champenois, Claire - 2018
The goal of this paper is to point out the role played by private equity investors (venture-capital companies and corporate investors) in the emergence of a new biotechnology industry in Germany in the second half of the 90's. This analysis takes into account the different business models and...
Persistent link: https://www.econbiz.de/10012706598
Cover Image
Venture Capital bedeutend für die Entstehung der Biotechnologiebranche
Champenois, Claire; Engel, Dirk; Heneric, Oliver - In: ZEW Gründungsreport 3 (2003) 1, pp. 1-2
15 Prozent der zwischen 1995 und 1999 neu gegründeten Biotechnologieunternehmen erhielten Venture Capital (VC). Am begehrtesten waren Medikamenten- und Wirkstoffentwickler sowie Dienstleister im Bereich medizinischer Anwendungen. Hier wurde nahezu jedes dritte Unternehmen mit VC finanziert.
Persistent link: https://www.econbiz.de/10011268515
Cover Image
The birth of german biotechnology industry : did venture capital run the show?
Champenois, Claire; Engel, Dirk; Heneric, Oliver - 2004
Persistent link: https://www.econbiz.de/10004791753
Cover Image
What kind of German biotechnology start-ups do venture capital companies and corporate investors prefer for equity investments?
Champenois, Claire; Engel, Dirk; Heneric, Oliver - In: Applied economics 38 (2006) 5, pp. 505-518
Persistent link: https://www.econbiz.de/10007634251